Suppr超能文献

[原发性和继发性肝肿瘤的射频消融术]

[Radiofrequency ablation in primary and secondary liver tumors].

作者信息

Carditello Antonio, Scisca Claudio, David Antonio, Stilo Francesco, Basile Maurizio

机构信息

Dipartimento di Discipline Chirurgiche Generali e Speciali, Policlinico Universitario G. Martino, Via Andria, 8, 98121 Messina.

出版信息

Chir Ital. 2002 Jan-Feb;54(1):83-6.

Abstract

The authors report the preliminary results of a new treatment for primary and secondary hepatic malignancies called radiofrequency ablation. Seven patients undergoing the new radiofrequency ablation procedure (4 M and 3 F; mean age 62 years) were studied. The 3 female patients were suffering from breast cancer metastases (1 case), left colon cancer metastases to the first hepatic segment with caval and portal compression (1 case), and metastases to the eighth hepatic segment from an operated left colon cancer (1 case). The 4 male patients were suffering from carcinoma of the first hepatic segment on a cirrhotic liver (1 case), two liver metastases from left a colon cancer (1 case), a single 3-cm diameter metastasis treated by laparotomic radiofrequency ablation after resection of a gastric cancer (1 case), and one metastasis to the eighth hepatic segment from an operated left colon cancer (1 case). Prior to treatment all patients were subjected to investigation of routine blood-chemistry parameters, hepatic enzymes, cancer markers (Ca 19.9, alphafetoprotein, cytokines), abdominal spiral CT or MRI or PET (18 FDG); and thorough ultrasonography. Four patients underwent percutaneous radiofrequency ablation; one patient with concomitant gastric cancer underwent laparotomic radiofrequency ablation and simultaneous removal of the tumour; one patient was treated by celioscopic radiofrequency ablation in the course of laparoscopic cholecystectomy; and one underwent transpleural-diaphragmatic radiofrequency ablation for metastases to the seventh and eighth hepatic segments. None of the patients undergoing ultrasonography and CT follow-up examinations after 6 months presented recurrence of hepatic metastases. This treatment, though its use has so far been limited to only a few cases with a short follow-up, opens up new prospects for the surgical treatment of primary and secondary malignancies, also in the light of experience based on a substantial number of patients, recently reported in the literature.

摘要

作者报告了一种针对原发性和继发性肝脏恶性肿瘤的新治疗方法——射频消融术的初步结果。研究了7例接受新射频消融术的患者(4例男性和3例女性;平均年龄62岁)。3例女性患者分别患有乳腺癌转移瘤(1例)、左结肠癌转移至第一肝段并伴有腔静脉和门静脉受压(1例)、左结肠癌术后转移至第八肝段(1例)。4例男性患者分别患有肝硬化肝脏第一肝段癌(1例)、左结肠癌肝转移2处(1例)、胃癌切除术后经剖腹射频消融治疗直径3厘米的单个转移瘤(1例)、左结肠癌术后转移至第八肝段(1例)。治疗前,所有患者均接受了常规血液化学参数、肝酶、癌症标志物(Ca 19.9、甲胎蛋白、细胞因子)、腹部螺旋CT或MRI或PET(18 FDG)检查;以及全面的超声检查。4例患者接受了经皮射频消融;1例合并胃癌的患者接受了剖腹射频消融并同时切除肿瘤;1例患者在腹腔镜胆囊切除术过程中接受了腹腔镜射频消融;1例患者因第七和第八肝段转移接受了经胸膜-膈肌射频消融。6个月后接受超声和CT随访检查的患者均未出现肝转移复发。这种治疗方法,尽管目前其应用仅限于少数病例且随访时间较短,但鉴于最近文献中报道的大量患者的经验,为原发性和继发性恶性肿瘤的手术治疗开辟了新的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验